Mike Stedman

1.4k total citations
71 papers, 734 citations indexed

About

Mike Stedman is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Genetics. According to data from OpenAlex, Mike Stedman has authored 71 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Endocrinology, Diabetes and Metabolism, 16 papers in General Health Professions and 11 papers in Genetics. Recurrent topics in Mike Stedman's work include Diabetes Management and Research (23 papers), Diabetes Treatment and Management (14 papers) and Diabetes Management and Education (10 papers). Mike Stedman is often cited by papers focused on Diabetes Management and Research (23 papers), Diabetes Treatment and Management (14 papers) and Diabetes Management and Education (10 papers). Mike Stedman collaborates with scholars based in United Kingdom, United States and Barbados. Mike Stedman's co-authors include Adrian Heald, David Miles, Mark Livingston, Mark Lunt, Roger Gadsby, Mark Davies, Gerry Rayman, Anthony A. Fryer, Simon Anderson and Martin Whyte and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Journal of Clinical Pathology.

In The Last Decade

Mike Stedman

64 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Stedman United Kingdom 14 267 104 104 101 96 71 734
Sohel Reza Choudhury Bangladesh 21 232 0.9× 46 0.4× 66 0.6× 54 0.5× 117 1.2× 92 1.3k
Firomsa Bekele Ethiopia 15 97 0.4× 133 1.3× 71 0.7× 67 0.7× 86 0.9× 61 751
Omar A. Almohammed Saudi Arabia 13 139 0.5× 88 0.8× 56 0.5× 30 0.3× 44 0.5× 71 606
Adeyemi Okunogbe United States 10 74 0.3× 56 0.5× 64 0.6× 73 0.7× 131 1.4× 25 849
Bishwajit Bhowmik Norway 17 438 1.6× 369 3.5× 24 0.2× 36 0.4× 90 0.9× 43 1.2k
James Lando United States 11 79 0.3× 69 0.7× 32 0.3× 52 0.5× 149 1.6× 15 822
Shajith Anoop India 15 238 0.9× 87 0.8× 29 0.3× 12 0.1× 57 0.6× 30 754
Carlos A. Fermín‐Martínez Mexico 11 76 0.3× 299 2.9× 22 0.2× 56 0.6× 62 0.6× 24 633
Ali Al Qarni Saudi Arabia 16 113 0.4× 56 0.5× 35 0.3× 12 0.1× 107 1.1× 59 701
Marjan Mosalman Haghighi Australia 14 38 0.1× 56 0.5× 72 0.7× 65 0.6× 106 1.1× 24 746

Countries citing papers authored by Mike Stedman

Since Specialization
Citations

This map shows the geographic impact of Mike Stedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Stedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Stedman more than expected).

Fields of papers citing papers by Mike Stedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Stedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Stedman. The network helps show where Mike Stedman may publish in the future.

Co-authorship network of co-authors of Mike Stedman

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Stedman. A scholar is included among the top collaborators of Mike Stedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Stedman. Mike Stedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taylor, Peter, Lakdasa Premawardhana, Mike Stedman, et al.. (2025). Risk of Death and Adverse Effects in Patients on Liothyronine: A Multisource Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 110(11). 3278–3288. 1 indexed citations
4.
Premawardhana, Lakdasa, et al.. (2024). Liothyronine (LT3) prescribing in England: Are cost constraints inhibiting guideline implementation?. Clinical Endocrinology. 101(1). 62–68. 2 indexed citations
5.
Heald, Adrian, Lakdasa Premawardhana, Peter Taylor, et al.. (2024). How Does Thyroid Hormone Profile Differ on and Off Replacement Treatment?. Clinical Endocrinology. 102(4). 490–495. 1 indexed citations
6.
Heald, Adrian, Mike Stedman, Angela Paisley, et al.. (2024). The Relation of Diabetes Complications to a New Interpretation of Glycaemic Variability from Continuous Glucose Monitoring in People with Type 1 Diabetes. Diabetes Therapy. 15(12). 2489–2498. 2 indexed citations
7.
Heald, Adrian, Mike Stedman, Angela Paisley, et al.. (2024). Unveiling the Spectrum of Glucose Variability: A Novel Perspective on FreeStyle Libre Monitoring Data. Diabetes Therapy. 15(12). 2475–2487. 1 indexed citations
8.
Stedman, Mike, Adrian Heald, David P. Holland, et al.. (2024). The Impact of Age and Sex on Fasting Plasma Glucose and Glycated Haemoglobin (HbA1c) in the Non-diabetes Population. Diabetes Therapy. 16(2). 257–267. 1 indexed citations
9.
Heald, Adrian, et al.. (2024). The lifetime healthcare costs of female obesity: modeling of England data and the costs of current pharmacotherapy. PubMed. 13(4). e00310–e00310. 1 indexed citations
10.
Stedman, Mike, Martin Whyte, Ian Laing, et al.. (2023). Failure to control conventional cardiovascular risk factors in women with type 2 diabetes might explain worse mortality. Diabetes/Metabolism Research and Reviews. 39(8). e3695–e3695. 4 indexed citations
11.
Stedman, Mike, George A. Dunn, Martin Gibson, et al.. (2023). Diabetes foot complications and standardized mortality rate in type 2 diabetes. Diabetes Obesity and Metabolism. 25(12). 3662–3670. 10 indexed citations
15.
Heald, Adrian, Mike Stedman, Rustam Rea, et al.. (2022). Distress and Living with Diabetes: Defining Characteristics Through an Online Survey. Diabetes Therapy. 13(9). 1585–1597. 4 indexed citations
16.
Stedman, Mike, Peter Taylor, Lakdasa Premawardhana, et al.. (2021). Trends in costs and prescribing for liothyronine and levothyroxine in England and wales 2011–2020. Clinical Endocrinology. 94(6). 980–989. 12 indexed citations
17.
Heald, Adrian, Kai Chang, Ting Jia, et al.. (2021). Longitudinal clinical trajectory analysis of individuals before and after diagnosis of Type 2 Diabetes Mellitus (T2DM) indicates that vascular problems start early. International Journal of Clinical Practice. 75(11). e14695–e14695. 2 indexed citations
18.
Stedman, Mike, Mark Lunt, Mark Davies, et al.. (2020). Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation. BMJ Open. 10(5). e033231–e033231. 41 indexed citations
19.
Heald, Adrian, Mike Stedman, Mark Davies, et al.. (2020). Quantifying the Impact of Patient-Practice Relationship Quality on the Levels of the Average Annual Antidepressant Practice Prescribing Rate in Primary Care in England. The Primary Care Companion For CNS Disorders. 22(1). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026